YHYara K. Haddad

Yara K. Haddad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yara K. Haddad has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Effect of an Intensive Geriatric Continuing Medical Education Program on the Implementation of STEADI ‐Based Fall Risk Screening

    by Colleen M. Casey, Alexandra C. Lesko, Helen On, Horia Marginean, Weston Anderson, Sharon Leigh, Yara K. Haddad, Rebecca B. Naumann, Jamie Caulley, Judy McConnachie, et al.

    Background: Universal fall risk screening as a first step to address falls has been endorsed in primary care but remains challenging due to competing clinical priorities and insufficient training. We studied the impact of our geriatric continuing medical education program, the Geriatric Mini‐Fellowship (GMF), on the uptake of fall risk screening in primary care over a 5‐year period. We hypothesized that primary care providers (PCP) with exposure to the GMF program would be more likely to implement fall risk screening than PCPs without direct or indirect program exposure. Population and Setting: We identified 133,068 patients ≥ 65 years of age who received care at primary care clinics in a large health system. Methods: Each year, we retrospectively assigned patients to one of three groups based on their provider's exposure to the GMF program. Groups included patients seen by: GMF providers who completed GMF training. GMF‐influenced providers who practiced at a clinic with at least one GMF provider. Usual care providers who neither completed GMF training nor worked at a clinic with a GMF provider. We described fall risk screening rates and patterns using multivariate models to estimate the predicted probability and odds of being screened each year based on a provider's training exposure. Results: GMF providers were associated with a greater predicted probability of screening patients for fall risk compared to usual care providers each year. Differences in predicted probabilities between GMF providers and usual care with bootstrapped confidence intervals favored GMF providers. Further, this screening advantage increased over time (2019: 5.8%, 2023: 12%). Conclusions: Our data supports intensive fall risk education on screening through a geriatrics training program to implement sustained fall risk screening in primary care. Screening is the first step in identifying high‐risk patients, which can enable assessment of modifiable risk factors and lead to targeted interventions.

  • Older Adult Falls as a Predictor of Nursing Facility Placement

    by Dawson S. Dobash, Yara K. Haddad, Ketra Rice, Gwen Bergen

    Background: Unintentional falls are a leading cause of injury, disability, and healthcare utilization among older adults (65+). Methods: Using the 2016–2021 Medicare Current Beneficiary Survey data, we examined the relationship between falls and nursing facility placement. Data from a cohort of 31 517 community-dwelling older adults were analyzed to assess fall prevalence at baseline and its association with nursing home placement in the following year. Multivariate regression models adjusted for demographic, health status, and functional limitations. Results: Falls were reported by 22.6% of participants at baseline and were higher among older females, white people, and those with poor health status, multiple chronic conditions, and existing functional limitations. Falls significantly increased risk of nursing home placement in the following year with an adjusted risk ratio (aRR) = 1.24 for any nursing facility, aRR = 1.51 for nursing home, and aRR = 1.18 for skilled nursing facilities. Conclusion: These findings underscore the strong association between falls and nursing facility placement, particularly among older adults with poorer health and multimorbidity. Preventative strategies targeting modifiable fall risk factors, such as strength and balance training, chronic disease management, and home safety intervention, could reduce fall incidence and the need for placement in nursing facilities.


  • Evaluating the effectiveness of a telemedicine-based STEADI implementation in primary care on fall outcomes: the STEADI options randomized controlled trial

    by Yara K Haddad, Matthew W Brault, Briana Moreland, Cora Peterson, Xinjian Zhang, Karen Thomas, Farah Sublett, Michelle Dougherty, Laurie Imhof, Madeleine E Hackney, et al.

    Background and Objectives: Falls are a leading cause of injury and death among older adults (65 years and above). The Centers for Disease Control and Prevention’s Stopping Elderly Accident, Deaths, and Injuries (STEADI) initiative aims to reduce falls by screening to find at-risk individuals, evaluation, and then addressing modifiable risk factors. This study evaluated the effectiveness of implementing a STEADI-based multi-component fall prevention approach via telemedicine in primary care. Research Design and Methods: A randomized controlled quality improvement trial (STEADI Options) was conducted during the COVID-19 pandemic (July 2020–December 2021). Primary care professionals (PCPs) were randomized to either standard-of-care (SOC) or intervention. The intervention included a fall risk assessment by a research nurse, who shared STEADI-based recommendations with PCPs. Recommended interventions were administered at the discretion of PCPs. Outcomes included self-reported falls (primary), medically treated falls, fall-related service utilization (physical therapy, occupational therapy, eye care, podiatry), and medication changes, assessed over one year. Analyses followed an intent-to-treat approach. Results: Among 660 participants (353 SOC; 307 intervention), the cohort was predominantly female (67.7%), aged 65–79 years (73.6%), and non-Hispanic White (56.1%). Intervention participants had higher average Stay Independent Screener (SIS) scores (6.3 vs. 5.2; p < 0.001). Overall, 5.5% reported a fall in the past 12 months. No significant differences were observed between groups in fall-related outcomes (e.g., medically treated falls odds ratio [adjusted for SIS]: 0.741; 95% CI: 0.411–1.336). Discussion and Implications: Although no significant differences were found, limited recruitment, low baseline fall rates, and unmeasured adherence may have impacted results. Further research is needed to evaluate the feasibility and effectiveness of telemedicine-based STEADI interventions in primary care.


  • Healthcare expenditure on older adult non-fatal falls by state

    by Gabrielle F Miller, Yara K Haddad, Neil Ortmann, Curtis Florence

    Objectives Falls are a leading preventable cause of death and injury among older adults (65+). Healthcare spending in the USA on non-fatal falls was estimated at $80 billion in 2020. We aim to estimate healthcare spending on older adult non-fatal falls by state. Methods Healthcare spending for all adults was derived from the 2020 Centers for Medicare and Medicaid Services (CMS) Health Expenditures by State of Residence files. These data covered three payor types: Medicare, Medicaid and private health insurance (PHI). Using the national 2020 CMS Health Expenditure by Age Group files, the national proportion of healthcare spending for older adults was calculated for each payor type. These national proportions were applied to each state’s healthcare spending data to estimate healthcare spending for older adults in each state, adjusted for the proportion of older adults in each state. To estimate the proportion of older adult healthcare spending attributed to non-fatal falls, these adjusted values were combined with the falls-attributable expenditure factors calculated in Haddad (2024). The final state-level estimates of healthcare spending on non-fatal older adult falls were calculated for each payer type: Medicare, Medicaid and PHI. All estimates were inflated to 2023 dollars. Results Overall state-level spending on non-fatal falls ranged between $112.7 million in Alaska to $8.3 billion in Florida. Per-capita spending estimates ranged between $1085 in Utah to $2262 in Wisconsin. Conclusions Measuring the cost of non-fatal falls at the state level can help inform regional differences and improve targeted fall prevention efforts.


  • Detection of ethanol, cannabinoids, benzodiazepines, and opioids in older adults evaluated for serious injuries from falls

    by Kavita M. Babu, Yara K. Haddad, Shakiera T. Causey, Carmen C. Vargas-Torres, Patricia Mae Martinez, Elizabeth M. Goldberg, Jon D. Dorfman, Julia A. Bleser, Brittany P. Chapman, Jeffrey T. Lai, et al.

    In 2020, there were 36.7 million reported falls among older adults (65+) in the United States. Ethanol and other sedating substances may increase fall risk among older adults due to their effect on cognitive and physical function. We estimate the prevalence of these substances in blood specimens of older adults presenting with a fall injury at selected trauma centers. The initial study collected blood specimens from May 2020 through July 2021 from adults undergoing a trauma team evaluation at selected United States Level 1 trauma centers. We limited our study to older adults evaluated after a fall (n = 1,365) and selected a random sample (n = 300) based on age, sex, and trauma-center quotas. Medical health records and blood specimens obtained at trauma center presentation were analyzed. We estimated the prevalence of ethanol, benzodiazepines, cannabinoids, and opioids in the blood specimens. Two-sample tests of binomial proportions and Chi-square two-tailed tests were used to compare prevalence estimates of substances by demographic characteristics. At least one substance was detected among 31.3% of samples analyzed. Prevalences of specific substances detected were 9.3% (95% CI: 6.0-12.6%) for benzodiazepines, 4.3% (95% CI: 2.0-6.7%) for cannabinoids, 8.0% (95% CI: 5.2-11.7%) for ethanol, and 15.0% (95% CI: 10.9-19.1%) for opioids. There were 18 deaths (6%; 95% CI: 3.6-9.3%). One-third of decedents had at least one substance detected in their blood. Opioids were the most frequently detected substance, followed by benzodiazepines, ethanol, and cannabinoids. Substance use prevalence was not uniform across demographics, with differences observed by sex and age. This study provides insight into the frequency of the presence of substances that may contribute to fall risk and serious injury among older adults. Screening older adults for substances that impair cognitive and physical function can enhance clinical fall prevention efforts.


  • Top Cited Papers
    Open Access

    Healthcare spending for non-fatal falls among older adults, USA

    by Yara K Haddad, Gabrielle F Miller, Ramakrishna Kakara, Curtis Florence, Gwen Bergen, Elizabeth Rose Burns, Adam Atherly

    Background The older adult (65+) population in the USA is increasing and with it the number of medically treated falls. In 2015, healthcare spending attributable to older adult falls was approximately US$50 billion. We aim to update the estimated medical expenditures attributable to older adult non-fatal falls. Methods Generalised linear models using 2017, 2019 and 2021 Medicare Current Beneficiary Survey and cost supplement files were used to estimate the association of falls with healthcare expenditures while adjusting for demographic characteristics and health conditions in the model. To portion out the share of total healthcare spending attributable to falls versus not, we adjusted for demographic characteristics and health conditions, including self-reported health status and certain comorbidities associated with increased risk of falling or higher healthcare expenditure. We calculated a fall-attributable fraction of expenditure as total expenditures minus total expenditures with no falls divided by total expenditures. We applied the fall-attributable fraction of expenditure from the regression model to the 2020 total expenditures from the National Health Expenditure Data to calculate total healthcare spending attributable to older adult falls. Results In 2020, healthcare expenditure for non-fatal falls was US$80.0 billion, with the majority paid by Medicare. Conclusion Healthcare spending for non-fatal older adult falls was substantially higher than previously reported estimates. This highlights the growing economic burden attributable to older adult falls and these findings can be used to inform policies on fall prevention efforts in the USA.


  • Open Access

    Telemedicine-Based Risk Program to Prevent Falls Among Older Adults: Protocol for a Randomized Quality Improvement Trial

    by David B Rein, Madeleine E Hackney, Yara K Haddad, Farah A Sublett, Briana Moreland, Laurie Imhof, Cora Peterson, Jaswinder K Legha, Janice Mark, Camille P Vaughan, et al.

    Background: The Center for Disease Control and Prevention’s Stopping Elderly Accidents, Deaths, and Injuries (STEADI) initiative offers health care providers tools and resources to assist with fall risk screening and multifactorial fall risk assessment and interventions. Its effectiveness has never been evaluated in a randomized trial. Objective: This study aims to describe the protocol for the STEADI Options Randomized Quality Improvement Trial (RQIT), which was designed to evaluate the impact on falls and all-cause health expenditures of a telemedicine-based form of STEADI implemented among older adults aged 65 years and older, within a primary care setting. Methods: STEADI Options was a pragmatic RQIT implemented within a health system comparing a telemedicine version of the STEADI fall risk assessment to the standard of care (SOC). Before screening, we randomized all eligible patients in participating clinics into the STEADI arm or SOC arm based on their scheduled provider. All received the Stay Independent screener (SIS) to determine fall risk. Patients were considered at risk for falls if they scored 4 or more on the SIS or answered affirmatively to any 1 of the 3 key questions within the SIS. Patients screened at risk for falls and randomized to the STEADI arm were offered a registered nurse (RN)–led STEADI assessment through telemedicine; the RN provided assessment results and recommendations to the providers, who were advised to discuss fall-prevention strategies with their patients. Patients screened at risk for falls and randomized to the SOC arm were asked to participate in study data collection only. Data on recruitment, STEADI assessments, use of recommended prevention services, medications, and fall occurrences were collected using electronic health records and patient surveys. Using staff time diaries and administrative records, the study prospectively collected data on STEADI implementation costs and all-cause outpatient and inpatient charges incurred over the year following enrollment. Results: The study enrolled 720 patients (n=307, 42.6% STEADI arm; n=353, 49% SOC arm; and n=60, 8.3% discontinued arm) from September 2020 to December 2021. Follow-up data collection was completed in January 2023. As of February 2024, data analysis is complete, and results are expected to be published by the end of 2025. Conclusions: The STEADI RQIT evaluates the impact of a telemedicine-based, STEADI-based fall risk assessment on falls and all-cause health expenditures and can provide information on the intervention’s effectiveness and cost-effectiveness. Trial Registration: ClinicalTrials.gov NCT05390736, http://clinicaltrials.gov/ct2/show/NCT05390736 International Registered Report Identifier (IRRID): RR1-10.2196/54395


  • Open Access

    Telemedicine-Based Risk Program to Prevent Falls Among Older Adults: Protocol for a Randomized Quality Improvement Trial (Preprint)

    by David B Rein, Madeleine E Hackney, Yara K Haddad, Farah A Sublett, Briana Moreland, Laurie Imhof, Cora Peterson, Jaswinder K Legha, Janice Mark, Camille P Vaughan, et al.

    BACKGROUND The Center for Disease Control and Prevention’s Stopping Elderly Accidents, Deaths, and Injuries (STEADI) initiative offers health care providers tools and resources to assist with fall risk screening and multifactorial fall risk assessment and interventions. Its effectiveness has never been evaluated in a randomized trial. OBJECTIVE This study aims to describe the protocol for the STEADI Options Randomized Quality Improvement Trial (RQIT), which was designed to evaluate the impact on falls and all-cause health expenditures of a telemedicine-based form of STEADI implemented among older adults aged 65 years and older, within a primary care setting. METHODS STEADI Options was a pragmatic RQIT implemented within a health system comparing a telemedicine version of the STEADI fall risk assessment to the standard of care (SOC). Before screening, we randomized all eligible patients in participating clinics into the STEADI arm or SOC arm based on their scheduled provider. All received the Stay Independent screener (SIS) to determine fall risk. Patients were considered at risk for falls if they scored 4 or more on the SIS or answered affirmatively to any 1 of the 3 key questions within the SIS. Patients screened at risk for falls and randomized to the STEADI arm were offered a registered nurse (RN)–led STEADI assessment through telemedicine; the RN provided assessment results and recommendations to the providers, who were advised to discuss fall-prevention strategies with their patients. Patients screened at risk for falls and randomized to the SOC arm were asked to participate in study data collection only. Data on recruitment, STEADI assessments, use of recommended prevention services, medications, and fall occurrences were collected using electronic health records and patient surveys. Using staff time diaries and administrative records, the study prospectively collected data on STEADI implementation costs and all-cause outpatient and inpatient charges incurred over the year following enrollment. RESULTS The study enrolled 720 patients (n=307, 42.6% STEADI arm; n=353, 49% SOC arm; and n=60, 8.3% discontinued arm) from September 2020 to December 2021. Follow-up data collection was completed in January 2023. As of February 2024, data analysis is complete, and results are expected to be published by the end of 2025. CONCLUSIONS The STEADI RQIT evaluates the impact of a telemedicine-based, STEADI-based fall risk assessment on falls and all-cause health expenditures and can provide information on the intervention’s effectiveness and cost-effectiveness. CLINICALTRIAL ClinicalTrials.gov NCT05390736, http://clinicaltrials.gov/ct2/show/NCT05390736 INTERNATIONAL REGISTERED REPORT RR1-10.2196/54395

  • A comparative analysis of selective serotonin reuptake inhibitors and fall risk in older adults

    by Yara K. Haddad, Ramakrishna Kakara, Zachary A. Marcum

    Background: One in five older adults (age 65+) uses an antidepressant medication. However, little is known about how fall risk differs between commonly prescribed medications. We examine the comparative association between individual selective serotonin reuptake inhibitors (SSRI) and self‐reported falls in older adults. Methods: We used data from 2010–2017 Medicare Current Beneficiary Surveys, a nationally representative survey of Medicare beneficiaries. We included participants from three different panels surveyed over two successive years. Participants were limited to community‐dwelling Medicare beneficiaries 65+, enrolled in Medicare Part D, and taking an SSRI ( n = 1023) during baseline years. Participants were asked about demographic and health characteristics, medication use (including dose, frequency, duration of use) and self‐reported falls as any fall or recurrent falls in the past year. We compared individual SSRI (citalopram or escitalopram vs sertraline) use by the average monthly total standardized daily dose (TSDD) and self‐reported falling, controlling for potential confounders. Descriptive analysis and multivariable logistic regressions were conducted using SAS‐callable SUDAAN. Results: Citalopram/escitalopram ( n = 460 users; 45.0% of all SSRI users) and sertraline ( n = 294 users; 28.7% of all SSRI users) were the most commonly prescribed SSRIs. Overall, 36.3% of citalopram/escitalopram users and 39.4% of sertraline users reported a fall in the year following medication use. There were no statistically significant differences between sertraline and citalopram/escitalopram users of either low or medium TSDD levels in the risk of self‐reported any or recurrent falls. However, users of high TSDD of sertraline (>75 mg) had a lower risk of recurrent falls compared to high TSDD citalopram (>30 mg) or escitalopram (>15 mg) daily for 30 days. Conclusion: These findings suggest a potential comparative safety benefit of sertraline compared to citalopram/escitalopram at high doses related to recurrent falls. Additional comparative studies of individual antidepressants may better inform fall risk management and prescribing for older adults.


  • Open Access

    National rates of non-fatal emergency department visits and hospitalisations due to fall-related injuries in older adults 2010–2014 and 2016: transitioning from ICD-9-CM to ICD-10-CM

    by Briana L Moreland, Elizabeth R Burns, Yara K Haddad

    Background This study describes rates of non-fatal fall-injury emergency department (ED) visits and hospitalisations before and after the US 2015 transition from the 9th to 10th revision of the International Classification of Diseases, Clinical Modification (ICD-9-CM to ICD-10-CM). Methods ED visit and hospitalisation data for adults aged 65+ years were obtained from the 2010–2016 Healthcare Cost and Utilisation Project. Differences in fall injury rates between 2010 and 2014 (before transition), and 2014 and 2016 (before and after transition) were analysed using t-tests. Results For ED visits, rates did not differ significantly between 2014 and 2016 (4288 vs 4318 per 100 000, respectively). Hospitalisation rates were lower in 2014 (1232 per 100 000) compared with 2016 (1281 per 100 000). Conclusion Increased rates of fall-related hospitalisations could be an artefact of the transition or may reflect an increase in the rate of fall-related hospitalisations. Analyses of fall-related hospitalisations across the transition should be interpreted cautiously.